Search
Displaying 1171 - 1180 of 1269
Omeros Corporation is sponsoring the ARTEMIS-IGAN clinical trial, a randomized, double-blind, placebo-controlled, Phase 3 study of the safety and efficacy of narsoplimab in patients with immunoglobulin A (IgA) nephropathy.
RENALINK: A PUBLICATION OF THE NKF Council of NEPHROLOGY NURSES & TECHNICIANS Council of NEPHROLOGY SOCIAL WORKERS Council on RENAL NUTRITION • CNNT Editor: Jennifer Lunt, CHT CNSW Editor: Jeff Harder, LICSW, NSW-C, FNKF CRN Editor: Elizabeth Sussman-Dabach, PHD, RD, FCRS • Editorial Manager: Cayla Guzewski...